The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer
Nakamura, Masato, Yamada, Yasuhide, Muro, Kei, Takahashi, Keiichi, Baba, Hideo, Sasaki, Yasutsuna, Komatsu, Yoshito, Satoh, Taroh, Mishima, Hideyuki, Watanabe, Masahiko, Sakata, Yuh, Morita, Satoshi,Volume:
11
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.15.59
Date:
May, 2015
File:
PDF, 1.78 MB
english, 2015